Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data

BACKGROUND: While many new medications may offer advantages over existing drugs, some newer drugs are reformulations of existing products that provide little innovation or incremental benefit while driving up drug costs. Despite the lack of benefit of these medications, prescribers may be motivated...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Manvi, Vadhariya, Aisha, Johnson, Michael L., Marcum, Zachary A., Holmes, Holly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880069/
https://www.ncbi.nlm.nih.gov/pubmed/29609611
http://dx.doi.org/10.1186/s12913-018-3043-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880069/
https://www.ncbi.nlm.nih.gov/pubmed/29609611
http://dx.doi.org/10.1186/s12913-018-3043-8

Ejemplares similares